drugset / Trial / NCT01758393
Glucocorticoids in Patients With IgG4-RD
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a randomized, open-label, single-center clinical trial to compare the efficacy and safety profile for medium-dose versus high dose glucocorticoid in patients with IgG4-related Disease. Patients will be followed for three months to measure the primary outcome and secondary outcomes.
Timeline
- Start
- 2012-12
- Primary completion
- 2014-01
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Prednisone | Other / unclassified | 0.5 mg/kg | — |
| Subject | Prednisone | Other / unclassified | 0.6 mg/kg | — |
| Subject | Prednisone | Other / unclassified | 0.8 mg/kg | — |
| Subject | Prednisone | Other / unclassified | 1 mg/kg | — |